Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001193125-26-461157·Easom Eric
Schedule 13G ownership disclosure
AN2 Therapeutics, Inc.
Common Stock, par value $0.00001 per share · CUSIP: 037326105
Event date: 2026-09-30
- Filing-level shares
- 2,409,486
- Percent of class
- 6.2%
- Eric Easom
Shares: 2,409,486 · Class: 6.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-26-461157
- Form type
- SCHEDULE 13G/A
- Filer
- Easom Eric
- CIK
- CIK 1914503
- Filed
- Nov 13, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership